乐动体育开户

Cardiac/Vascular Intervention

Top Story

VIRTUS: Venous stent safe, effective at 24 months

VIRTUS: Venous stent safe, effective at 24 months
February 9, 2020
At Issue

At Issue: Early risk identification, addressing disparities key for women’s heart health

February 7, 2020
February is American Heart Month, and Feb. 7 is National Wear Red Day, an American Heart Association initiative that aims to raise awareness of heart disease as the…

Azar: HHS ‘should be very proud’ of its achievements, life expectancy among them

February 7, 2020
The past 3 years were marked by historic accomplishments that put HHS in a strong position to tackle the challenges that lie ahead, HHS Secretary Alex Azar II
Meeting News

Low-dose paclitaxel-coated balloon noninferior to higher-dose balloon

February 6, 2020
A low-dose paclitaxel-coated balloon was similar in safety and efficacy to a higher-dose one for treatment of patients with peripheral artery disease, according to the…
Meeting News

DCB remains superior to PTA at 1 year in treatment of arteriovenous fistula lesions

February 6, 2020
A drug-coated balloon was superior to percutaneous transluminal angioplasty at 1 year for primary patency and clinically driven target lesion revascularization in…
More Headlines »
The Take Home

The Take Home: CRT

Cardiology Today's Intervention, May/June 2019
Cardiovascular Research Technologies (CRT) was held March 2 to 5 in Washington, D.C., and Cardiology Today’s
More »
Video
Meeting News

VIDEO: PFO closure effectiveness to be tested in real-world population

June 8, 2019
More »
Resource Centers
American Heart Association

American Heart Association

Meeting News

VIRTUS: Venous stent safe, effective at 24 months

February 9, 2020
Among patients with challenging venous lesions, a venous stent was associated with high rates of primary patency and…
More »